Anger and Psychotrauma: Data From Military and Civilians
NCT ID: NCT04518267
Last Updated: 2023-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2020-09-21
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Within the Anglo-Saxon literature, it is recognized that both civilians and military personnel with PTSD exhibit high levels of anger, with a possible predominance among military personnel. While we know that anger management mechanisms can be strongly influenced by cultural aspects and the type of event, there is no data in the French population.
This study proposes to fill in our knowledge of anger-PSTD relationships in the French population and by comparing civilian and military population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Group CBT for Aggression in Veterans
NCT02233517
Mindfulness Treatment for Anger in Veterans With PTSD
NCT02882802
Attachment and Post-Traumatic Stress Disorder in Military Personnel: Characterization of the French Military Population, Exploration of Biopsychosocial Factors, and Study of the Impact of Security Priming on Emotional Contagion Capacities
NCT06996275
Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans
NCT02157779
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
NCT01228539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Civilian group
Participants with civilian status
Structured clinical interview
A structured clinical interview will be performed at enrollment.
Psychological questionnaires
Several psychological questionnaires will be performed at enrollment.
Military group
Participants with military status
Structured clinical interview
A structured clinical interview will be performed at enrollment.
Psychological questionnaires
Several psychological questionnaires will be performed at enrollment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured clinical interview
A structured clinical interview will be performed at enrollment.
Psychological questionnaires
Several psychological questionnaires will be performed at enrollment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be at least 18 years of age
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre hospitalier d'Arras
Arras, , France
Centre régional psychotrauma Hauts-de-France
Lille, , France
3ème Centre médical des Armées
Lille, , France
Centre Hospitalier de Cadillac
Lormont, , France
CHU de Nice
Nice, , France
CHU-Lenval hôpitaux
Nice, , France
Centre Hospitalier Léon-Jean Grégory de Thuir
Thuir, , France
Groupe Hospitalier Paul Guiraud
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00507-32
Identifier Type: OTHER
Identifier Source: secondary_id
2019PPRC16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.